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Abstract
Arterial compliance (C) is related to the elasticity, size, and geometrical distribution of arteries. Compliance is a determinant of the
load that impedes ventricular ejection. Measuring compliance is difficult, particularly in the pulmonary circulation in which resistive
and compliant vessels overlap. Comparing different methods for quantification of compliance to a method that involves a con-
tinuous flow might help to identify the optimal method. Pulmonary arterial compliance was computed in six pigs based on the
stroke volume to pulse pressure ratio, diastolic decay exponential fitting, area method, and the pulse pressure method (PPM).
Compliance measurements were compared to those obtained under continuous flow conditions through a right ventricular bypass
(Heartware Inc., Miami Lakes, FL, USA). Compliance was computed for various flows using diastolic decay exponential fitting after
an abrupt interruption of the pump. Under the continuous flow conditions, resistance (R) was a decreasing function of the flow,
and the fitting to P¼ e-t/RC yielded a pulmonary time constant (RC) of 2.06 s ( 0.48). Compliance was an increasing function of
flow. Steady flow inter-method comparisons of compliance under pulsatile flow conditions showed large discrepancies and values
(7.23 4.47mL/mmHg) which were lower than those obtained under continuous flow conditions (10.19 1 0.31mL/mmHg).
Best agreement with steady flow measurements is obtained with the diastolic decay method. Resistance and compliance are
both flow-dependent and are inversely related in the pulmonary circulation. The dynamic nature of the pulsatile flow may induce a
non-uniformly distributed compliance, with an influence on the methods of measurement.
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Introduction
The pulmonary circulation is a low-resistance high-compli-
ance system that exhibits certain remarkable functional
properties distinguishing it from the systemic circulation.
For instance, it has been reported that the product of pul-
monary vascular resistance (R) and total pulmonary artery
(PA) compliance (C), RC, is constant,1 which might explain
the observation that the systolic pulmonary artery pressure
(SPAP) relates linearly to the mean pulmonary pressure
(mPAP).2 This behavior has been ascribed to the anatomical
and physiological organization of the pulmonary arterial
vasculature, with the extension of compliant vessels to the
capillary level, overlapping the resistive vessels.3
However, clinical and experimental studies have shown
discrepancies in the RC product, questioning its constancy.4
The methodological nature of these studies, however, may
contribute to this uncertainty. While resistance is calculated
in a well-deﬁned and undisputed manner as (mPAP–left
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atrial pressure)/mean ﬂow), there are several ways to calcu-
late pulmonary arterial compliance, which may explain the
disparities observed among several studies. All methods
used to estimate volume compliance are implicitly or expli-
citly based on Windkessel models, which are a relatively
crude approximation of a more complex physiological
reality. These models do not account for wave travel;
however, the estimates are based on pressure and ﬂow meas-
urements which are aﬀected by waves and wave reﬂections,
and thereby inﬂuence the accuracy of the compliance
measurement.5
The primary goal of this study was to design an in vivo
experimental model to quantify the pulmonary vascular
response to steady ﬂow. A continuous ﬂow pump was
used to bypass the right ventricle thereby creating a non-
pulsatile steady state in the pulmonary vasculature that is
unaﬀected by waves. We hypothesized that a net interrup-
tion of the ﬂow would induce a mono-exponential pressure
decay as described by Franck, which would allow for the
extraction of a time constant (RC).6 This methodology
should allow for the veriﬁcation of the constancy of RC
and the identiﬁcation of the more appropriate method
for calculating compliance compared with other methods.
A reliable measurement of compliance in the pulmonary
circulation is clinically relevant and can eventually
allow for a better outlining of the prognosis of patients
with pulmonary arterial hypertension (PAH), the determin-
ation of the operability of patients with certain forms
of pulmonary hypertension,7 and the reﬁnement of the man-
agement of PAH patients who are in need of left and/or
right ventricular assist devices.8
Materials and methods
The study protocol was performed according to the stand-
ards of The Guide for the Care and Use of Laboratory
Animals, published by the National Institutes of Health
(publication 85-23, revised 1996) and approved by the
Ethical Committee for Animal Research of the Ghent
University Hospital (ECD 15/46).
Experimental preparation
Six landrace pigs (all animals were female pigs aged six
months; the average weight was 68.3 10.4 kg) were
included in the study. Following a pre-treatment of intra-
muscular tiletamine and zolazepam in a combined solution
with xylazine 2% (0.2mL/kg), anesthesia was induced with
intravenous propofol (3mg/kg), sufentanil (0.005mg/kg),
and rocuronium bromide (1mg/kg). After the endotracheal
intubation, the animals were mechanically ventilated with
40% FiO2 and a tidal volume of 0.1–0.15L/kg. The anes-
thesia was maintained with a continuous sevoﬂurane ET
(2.5%) administration via the AnaConda System (Sedana
Medical, Sundbyberg, Sweden) and eventually with add-
itional boluses of sufentanil (0.005mg/kg). Basic monitoring
included an electrocardiogram, body temperature measure-
ment, and ventilatory CO2 emission measurements via cap-
nography. Arterial blood gas sampling was used to control
the oxygenation.
A central venous line was inserted via the external jugular
vein for a saline infusion at a constant rate of 3–5mL/kg/h.
The left carotid artery was punctured and a single lumen
ﬂuid-ﬁlled catheter was used to continuously monitor the
systemic pressures.
Pulsatile flow conditions (normal physiology)
The heart was exposed through a midline sternotomy and
longitudinal opening of the pericardium. A pressure trans-
ducer-tipped catheter (Millar SPR-524; Millar Instruments,
Houston, TX, USA) was inserted into the PA with the tip at
the level of the main pulmonary trunk.
A 16-mm perivascular ﬂow probe (Transonic Systems,
Ithaca, NY, USA) was placed around the PA for continu-
ous measurement of PA ﬂow. A second pressure transdu-
cer-tipped catheter (Millar SPR-524; Millar Instruments,
Houston, TX, USA) was inserted into the left atrial
appendage to monitor left atrial pressure (LAP), and a 7-
F dual-ﬁeld pressure-volume catheter (Millar SPC-570-2 ,
Millar Instruments, Houston, TX, USA) was inserted via
direct puncture into the right ventricle to monitor intraven-
tricular pressures. The pressure and ﬂow in the PA and the
left atrial and right ventricular pressure were recorded at
baseline and during dobutamine continuous infusion
(15mgr.kg1.min1) to increase cardiac output and pul-
monary pressures (Fig. 1).
Steady flow conditions (novel experimental protocol)
During a second phase, the PA perivascular ﬂow probe was
removed and the PA was encircled using umbilical tape with
a tourniquet to constrict the PA. A 29-Fr multi-perforated
cannula (Sto¨ckert Instruments, Mu¨nchen, Germany) was
inserted into the right atrium, and a straight 22-Fr cannula
(Medtronic Inc., Minneapolis, MN, USA) was inserted into
the PA through the right ventricular outﬂow tract and
secured with a 5/0 prolene purse-string suture. The cannulas
were connected to a continuous centrifugal ﬂow pump
(Heartware Inc., Miami Lakes, FL, USA) via two silicon
tubes, a 31-Fr tube at the inﬂow side and a 27-Fr tube at
the outﬂow side (Fig. 1). The pump was started at 2000
rotations/min and the tourniquet was tied around the PA
cannula to ensure that all pulmonary ﬂow was exclusively
delivered via the continuous ﬂow pump. The exact pump
ﬂow rate was recorded via a ﬂow probe (MA-16 PAU,
Transonic Systems, Ithaca, NY, USA) that was adapted
around the arterial tubing. The pump ﬂow was progressively
increased with increments of 100 rotations/min until
the ﬂow doubled. Per increment increase, the ﬂow was
abruptly interrupted with a clamp to measure the pressure
decrease in the PA.
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Data acquisition and processing
All pressures, ﬂows, and intraventricular volume were rec-
orded and digitized at 1000Hz using a data acquisition
system (Powerlab 16/9, Ad Instrument, Dunedin, New
Zealand) and software (Labchart 7, Ad Instrument,
Dunedin, New Zealand). The recordings were done with
the animal disconnected at least 5 s from the ventilator to
Fig. 1. Experimental setting. (a) Pulsatile flow setting. (b) Recordings from top to bottom are as follows: right ventricular pressure, right
ventricular volume, pulmonary pressure, pulmonary flow, left auricular pressure and systemic pressure. (c) Continuous flow setting. (d) One
occlusion episode is shown from top to bottom: pump flow, systemic pressure, and pulmonary pressure.
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achieve airway pressure equal to the atmospheric pressure.
The data analysis was performed using embedded or
custom-made functions programmed in a MATLAB envir-
onment (MATLAB, Mathworks, Natick, MA, USA).
Assessing total pulmonary arterial compliance under
pulsatile flow conditions
Pulmonary arterial compliance was computed according to
the following four methods:
1. The ratio of stroke volume (in mL) and pulse pressure (in
mmHg). The stroke volume was measured using the inte-
gral of the positive values of the PA ﬂow meter; negative
values were discarded.
2. Diastolic pressure decay time method. During diastole,
the pressure drops mono-exponentially in a Windkessel
system according to the following equation:
P ¼ Pdiastet=RC ð1Þ
Fitting the diastolic pressure curve to an exponential
curve yields RC, where R is resistance calculated as
(mPAP–PLAP)/mean ﬂow. Because the ﬁrst portion of
diastole is perturbed by waves, we started the ﬁtting
after the peak value of diastolic pressure.
3. The area method initially described by Liu.9 The area
method divides the cardiac cycle into two areas, systole
and diastole, based on the incisura of the dicrotic notch.
We deﬁned the onset of the diastolic period and area
as the period during which no ﬂow entered the vascular
circuit, and thus, a ventricular volume reduction was not
observed via the impedance catheter. This instant deﬁnes
the pressure at the beginning of the diastole (Pdiast), split-
ting the systolic (As) and diastolic (Ad) areas (Fig. 2).
Compliance is calculated as
C ¼ Stroke volume
K Pdiast  Pend diastð Þ with K ¼
ðAs þ AdÞ
Ad
ð2Þ
with Pend diast deﬁned as the pressure at the end of the
diastole in mmHg.
4. The pulse pressure method.10,11 According to Stergiopulos
et al., this method iteratively adapts the value of C in a
two-element Windkessel model until the measured
and predicted pulse pressures are identical, considering a
calculated value of R.
Assessing total pulmonary arterial compliance under
continuous flow conditions
Compliance computation under continuous ﬂow conditions
is based on the PA pressure decay once the ﬂow is abruptly
ceased. The pressure decrease was best ﬁtted by a bi-expo-
nential decay function rather than a mono-exponential
Fig. 2. Modified area method to compute compliance. (a) The beginning of the diastolic phase is usually defined at the first dicrotic peak (black
arrow) and the corresponding area is shaded in (b). We used the conductance catheter to identify the moment when there is no outflow from the
ventricle (large gray arrow) and started the diastole at the corresponding pressure recording, which enlarged the diastolic area shaded in (c).
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function; however, when only considering the ﬁrst 500ms of
the pressure curve, a mono-exponential ﬁt is reasonable
(R2¼ 0.99) (Fig. 3) and compliance is computed by the
same equation as that used under the pulsatile ﬂow condi-
tions as follows: P¼Pdiast e-t/RC.
Assessing pulmonary arterial resistance and RC
The resistance was calculated as (mPAP–PLAP)/mean ﬂow.
The RC is either the product of the resistance and compli-
ance when they are individually derived (using the area
method, SV/PP method, and pulse pressure method) or
the value obtained from the ﬁtting of the exponential
curve using the decay method (in pulsatile and continuous
ﬂow conditions).
Statistics
The comparison between the pulsatile and continuous ﬂow
conditions was performed using the Wilcoxon-signed rank
test. The comparisons in-between animals were performed
using a Kruskal–Wallis analysis. Correlations were estab-
lished using Spearman’s correlation. Comparisons between
the diﬀerent types of compliance measurements were
performed using the Bland–Altman method of agreement.12
The test results were considered statistically signiﬁcant at
P< 0.05.
Results
Relationship between mPAP and SPAP
The arterial pressures (mPAP and SPAP) that were recorded
under pulsatile ﬂow conditions were averaged over 10 beats
in end-expiratory conditions. Every animal had ﬁve record-
ings distributed during the experiment under pulsatile con-
ditions. The recordings yielded 30 pairs of values (SPAP and
mPAP) for the six animals. The analysis of the pooled data
demonstrated that mPAP and SPAP were linearly related
according to the following equation: mPAP¼ 0.59
SPAPþ 2.48mmHg (r2¼ 0.913) (Fig. 4).
Pulmonary arterial compliance under pulsatile
flow conditions
The values of compliance under pulsatile ﬂow conditions
using the four diﬀerent methods at baseline and following
dobutamine infusion are presented in Table 1. In all animals
except for one, dobutamine infusion suﬃciently increased
the ﬂow, allowing for the calculation of compliance at two
signiﬁcantly diﬀerent ﬂow levels. In each animal, the
increase in ﬂow was accompanied by a moderate increase
of PA pressure and signiﬁcant decrease of resistance. None
of the four methods used to estimate compliance under pul-
satile ﬂow conditions provided consistent trends during
dobutamine administration (Table 1). In animal 3, for
example, compliance decreased with dobutamine using the
pulse pressure method and SV/PP method, while higher
values were found using the two other methods. We high-
lighted in gray the pairs of values where a decrease in resist-
ance supposed an increase of compliance and instead a
Fig. 3. Mono-exponential fitting of the pressure decay curve over the
whole decay (a) is less satisfactory than a bi-exponential decay (b).
However, considering the first 500ms (c), the mono-exponential fitting
yielded satisfactory results. Fig. 4. The linear relationship between the mPAP and the SPAP.
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decrease was observed. This ‘‘paradoxical’’ evolution
occurred once with the decay method, twice with the area
method, four times with the PPM method, and ﬁve times
with the SV method.
Assessing the pressure-flow relationship and total
pulmonary arterial compliance under continuous
flow conditions
Fig. 5a shows the pump rate to pressure relationship. In ﬁve of
the six animals, PAP remained constant (the 95% conﬁdence
interval of a linear ﬁt crosses 0 for the angular coeﬃcient [pigs 5
and 6]) or slightly increased with the pump rate increase (pigs 1,
2, and 3: maximum angular coeﬃcient< 0.002). One animal
showed an obvious decrease of PAP as the pump rate increased
(pig 4: angular coeﬃcient of –0.004). Fig. 5b shows the rela-
tionship between the ﬂow and resistance and indicates that
there is a decrease of resistance with increasing ﬂow. Fig. 5c
shows the relationship between the ﬂow and compliance. In all
animals, there is an increase of compliance with increasing ﬂow.
Combining R and C in Fig. 5d, it was observed that RC was
fairly constant in each animal with increasing ﬂow, except for
pig 3, which showed an RC decrease.
In the individual animals, the average RC over all ﬂow
levels varied from 1.13 0.36 s (pig 1) to 2.91 s 0.20 (pig
2), resulting in statistically signiﬁcant diﬀerence between
animals (P< 0.01). When the RC product was normalized
for the weight, it varied from 0.023 0.04 s (pig 1) to
0.039 0.001 s (pig 2) and the diﬀerence remained statistic-
ally diﬀerent.
Comparing the pulsatile and continuous regimes
The ﬂow at which compliance was measured in the pulsatile
regime (Table 1) was used as the reference. The diﬀerent
ﬂows in the continuous regime were screened and the ﬂow
closest to the reference value was chosen. The concomitant
compliance value was then compared with that obtained
under the pulsatile ﬂow conditions. The ﬂows selected
(two for each animal except for pig 1 for which only one
value was available) are presented in Table 2. Some of the
ﬂow levels in the pulsatile regime were low and were not
reproduced by the continuous ﬂow. Compliance values
were signiﬁcantly higher under continuous ﬂow conditions
than under pulsatile ﬂow conditions regardless of the used
measurement method with a very poor correlation. With
compliance measured in the continuous ﬂow regime as ref-
erence, Bland–Altman analysis showed a Pearson correl-
ation coeﬃcient of 0.021 for the decay method, 0.027 for
the SV method, 0.101 for the PPM method, and 0.317 for
the area method.
In the pulsatile regime, when plotting C as a function of
R, no evident relationship emerges whatever the method
considered, whereas in the continuous ﬂow regime, there is
an inverse relationship according to the following equation:
Resistance ¼ 2:52  compliance0:88 ðR2 ¼ 0:84Þ Fig:6ð Þ:
Discussion
In this study, we designed an experimental setting and meth-
odology that provides a reliable method for compliance
measurements by eliminating wave perturbations in the
pressure curves in the pulmonary circulation. Compared
to this measurement, all conventionally used methods
appear to underestimate compliance and lead to large dis-
crepancies between other compliance estimations.
The use of a continuous ﬂow pump allowed for the cre-
ation of steady conditions in the pulmonary circulation,
Table 1. Compliance measurement in pulsatile flow.
Flow P mean Lap R Period SV C (SV/PP) C (decay) C (area) C (ppm)
Pig 1 BL 39.45 20.96 8.65 0.312 0.74 33.71 2.77 (0.02) 2.97 (0.04) 1.93 (0.02) 1.66
Pig 1 DOBU 41.02 20.55 7.90 0.308 0.72 34 .01 2.66(0.03) 2.94 (0.03) 1.99(0.02) 1.70
Pig 2 BL 35.91 21.88 2.95 0.527 0.67 23.10 1.32 (0.03) 1.41 (0.02) 1.72 (0.05) 0.73
Pig 2 DOBU 66.96 29.12 5.37 0.355 0.39 25.77 0.74 (0.03) 0.73 (0.03) 0.74 (0.08) 0.35
Pig 3 BL 17.47 17.95 7.05 0.623 0.89 27.08 2.23 (0.06) 1.99 (0.07) 1.41 (0.04) 1.51
Pig 3 DOBU 44.33 20.22 8.47 0.265 0.72 39.13 1.91 (0.09) 2.55 (0.26) 1.51 (0.06) 1.39
Pig 4 BL 27.32 10.38 3.56 0.249 0.62 16.95 1.88 (0.02) 1.19 (0.03) 1.88 (0.10) 0.38
Pig 4 DOBU 48.54 12.43 3.17 0.191 0.61 29.87 1.57 (0.03) 1.95 (0.03) 2.83 (0.15) 0.59
Pig 5 BL 47.14 13.53 4.49 0.192 0.66 41.24 4.38 (0.13) 2.79 (0.20) 3.47 (0.22) 2.97
Pig 5 DOBU 59.84 14.43 4.92 0.159 0.62 44.54 3.94 (0.06) 3.28 (0.18) 5.60 (0.36) 1.97
Pig 6 BL 24.68 13.78 6.23 0.306 0.71 23.26 2.22 (0.05) 3.04 (0.09) 1.58 (0.09) 1.18
Pig 6 DOBU 32.93 15.36 7.01 0.253 0.60 23.61 1.68 (0.02) 3.50 (0.15) 1.32 (0.09) 1.09
Flow is expressed in mL/s.
Pairs of compliance values where a decrease are observed instead of the expected increase are highlighted in gray.
P mean, mean pressure in mmHg; Lap, left atrial pressure in mmHg; R, resistance in mmHg.ml1.s; Period, heart cycle duration in seconds; SV, stroke volume in mL;
C, compliance in mL.mmHg1.
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thereby eliminating the dynamics caused by the transmitted
and reﬂected waves from pressure and ﬂow recordings.
Consequently, the pressure/ﬂow relationship at equilibrium,
without elastic variations, only corresponds to the vascular
resistance, dismissing eﬀects of inertance and compliance
(which both contribute to the complex input and character-
istic impedance). The abrupt interruption of the ﬂow after
an equilibrium state has been reached allows for an approxi-
mation that is close to a two-element Windkessel conﬁgur-
ation, which is conﬁrmed by the monotonically decaying
pressure, consistent with the discharge of a loaded capaci-
tance. We therefore believe that an exponential ﬁtting to the
pressure decrease yields a reference value for pulmonary
compliance.
The purpose of our study was not to validate this method
for clinical use in humans but to identify the best invasive
method of compliance estimation among the few usable
methods available in the human clinic, which could then
be used as a standard for comparisons with less invasive
methods, such as MRI.13 Interestingly, the values obtained
for the resistance and compliance under continuous ﬂow
conditions were signiﬁcantly lower and higher, respectively,
than those under the pulsatile ﬂow conditions. Moreover,
this observation seemed to be independent of the used
method of compliance estimation.
Regarding the resistance, we observed a decrease as the
pump ﬂow increased, which we ascribe to the progressive
recruitment of under-perfused vessels and/or vessel dilata-
tion with increasing pump ﬂow rates.14 The ﬂow-resistance
curves can be approximated by an exponential ﬁtting or a
second power ﬁtting. More important is the observation
Fig. 5. (a) Pressure vs. pump flow rate; (b) resistance vs. flow; (c) compliance vs. flow; (d) RC vs. flow.
Table 2. Compliance measurement in continuous flow.
Flow P mean Lap R C
Pig 1 39.31 14.81 5.94 0.225 4.43
Pig 2 36.66 15.62 2.75 0.369 8.27
Pig 2 65.66 16.36 4.34 0.183 15.04
Pig 3 17.47 NA NA NA NA
Pig 3 44.50 18.90 5.62 0.305 6.55
Pig 4 27.32 NA NA NA NA
Pig 4 35.51 14.93 3.26 0.329 4.92
Pig 4 48.23 13.08 5.03 0.168 10.68
Pig 5 47.50 15.07 4.93 0.213 10.91
Pig 5 59.66 15.12 6.79 0.140 16.34
Pig 6 24.68 NA NA NA NA
Pig 6 34.27 22.51 6.33 0.469 3.53
Flow is expressed in mL/s.
P mean, mean pressure in mmHg, Lap, left atrial pressure in mmHg; R, resist-
ance in mmHg.mL1.s; C, compliance in mL.mmHg1; NA, not applicable.
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that a 5% increase of the ﬂow entailed a 10–25% decrease of
the resistance. Despite that a constant value is not applicable
to the pulmonary resistance,15 most clinical studies use
resistance as a single value without normalization for the
variability in body surface or ﬂow.16 Further studies are
needed to identify the type of ﬂow normalization that
should be applied to adjust for the resistance.
Whether the observed decrease in resistance is due to a
passive mechanical eﬀect or mediated by a decreased vaso-
motor tone is a relevant question that cannot be answered in
our study since vasomotor tone was not blocked. Although
it is a very important topic in the pulmonary circulation
witnessed by positive clinical results on pulmonary vasodila-
tors17 and by the physiological relevance of hypoxic vaso-
constriction,18 the exact role and pathways of pulmonary
vasomotor tone in normal lungs at rest and at exercise is
still under investigation with some argument in favor of
passive control19 and some for active control.20 Transition
from pulsatile shear stress to constant shear stress should
have an impact on vasoactive mediators; however, the phe-
nomenon is complex and deserves attention that extends the
primary goal of our experiment.
The compliance/Windkessel eﬀect leads to the monoton-
ically decaying pressure upon cessation of ﬂow.
Interestingly, the abrupt ﬂow interruption induces a bi-
exponential decay of pressure rather than a mono-exponen-
tial decay (Fig. 3). This bi-exponential decay has previously
been described and has been explained by a compartmental
design of the pulmonary vasculature: there could be a
sequential voiding from the arterial compartment into the
capillary bed and from there in the venous compartment.21
The capillary bed led to particular interest since the capillary
pressure could be a determinant of the alveolar transmural
pressure. Quantiﬁcation of the pressure through the bi-expo-
nential decay to help diagnosis and therapy of lung dis-
orders such as pulmonary edema or ARDS has been
extensively investigated but with poor positive results.22
Resistance partitioning to predict operability of CTEPH
was also explored with the bi-exponential method with lim-
ited applications.23
The design of the continuous ﬂow model adopted in this
experiment uniformize the ﬂow and the pulmonary vascula-
ture can be more properly viewed as a continuously distrib-
uted resistance-compliance system. All the aforementioned
arterial, capillary, and venous compartments are abolished,
and still bi-exponential decay is observed. The sequential
voiding of compartments can hardly be defended in our
continuous ﬂow setting to account for a bi-exponential pres-
sure decrease.
The non-linearity of the vascular resistance is suﬃcient to
justify a bi-exponential decay (or, more generally, a multi-
exponential decay), hereby questioning the use of the capil-
lary pressure as a measure of resistance partitioning in the
clinical setting.
Since a bi-exponential decrease cannot be used to extract
a value for compliance, we had to consider ﬁtting only a part
of the pressure decay in compliance computations under
continuous ﬂow conditions We chose a time interval larger
than a half period of the average heart rate based on the
assumption that a large time interval would reﬂect the dia-
stole and yield acceptable values for our derived measures;
this time interval was suitable for a mono-exponential
decrease analysis.
The value of compliance obtained with this methodology
are signiﬁcantly higher than the values obtained in the pul-
satile ﬂow regime.
Getting rid of waves and wave reﬂections was the prem-
ises of the use of the continuous ﬂow pump, the objective
being to be as close as possible to a two-element Windkessel;
however, it resulted in a uniformization of the diﬀerent com-
partment of the vascular tree, the compliance measured
being the addition of the arterial, capillary, and venous
sector hence the observed compliance is high. The continu-
ous ﬂow setting cannot be used as a gold standard to deter-
mine the compliance of the arterial compartment that is the
most valuable for the clinician. Nevertheless, the setting can
still be used to assess the relation of the resistance and
compliance.
The RC time constant of the pulmonary arterial bed
Otto Franck was the ﬁrst to formalize the Windkessel
function of the arterial system by considering the dia-
stolic pressure a mono-exponential decay in the formula
P¼Pdiast e -t/RC under zero inﬂow conditions. Franck
noticed that the ratio of the time derivative of pressure to
the pressure should then be constant, i.e. RC.6 However, his
deduction did not consider the impact of waves disturbing
the pressure analysis. In the normal pulmonary circulation,
the diastolic part of the pressure curve is severely distorted
from a mono-exponential; ﬁtting is typically restricted to
approximately the last one-third of diastole. However,
under continuous ﬂow conditions, the wave perturbations
are abolished and a mono-exponential curve ﬁts well to the
pressure decay during the ﬁrst 500ms following ﬂow cessa-
tion. This allows for measurements of the RC time constant
over a wide range of ﬂow variations.
RC has been reported to be a constant with a mean value
of 0.5 s in every patient regardless of the pathology.24 The
constancy of RC is a surrogate for another remarkable
property of the pulmonary hemodynamic, i.e. the linear
relationship between the mean and the systolic pressure.
This relationship has been demonstrated in healthy25,26
and diseased states27 and under diﬀerent physiological con-
ditions.28 This pressure relationship has been shown to be
related to the constancy of the RC product.1
In our study, we showed that mPAP and SPAP are lin-
early related as mPAP¼ 0.59 SPAPþ 2.48, which is remark-
ably close to what has been observed in humans
(mPAP¼ 0.6 SPAPþ 2).29 While the linear relationship
between SPAP and mPAP is widely supported in literature
(with some notable modulation in chronic thrombo-embolic
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patients),30,31 its putative cause, the constancy of RC, is not
unequivocally accepted and is associated with wide vari-
ations (from 0.25 s32 to 0.75 s33) around the mean value of
0.5 s. One of the possible causes of this variability might be
related to the methodology of the RC measurement, which
is often computed as the product of the resistance and com-
pliance (deﬁned as SV/PP), hereby being subject to mathem-
atical coupling.34
Due to the design of this experiment, we could reliably
assess the RC. In ﬁve of the six animals, the RC was eﬀect-
ively constant with only a slight variation around the mean
value (Fig. 5).
While the RC product was constant within most animals,
values were signiﬁcantly diﬀerent among the animals. Two
diﬀerent approaches of the time constant should be con-
sidered. One approach is the time for the pressure to
decrease to one-third of its protodiastolic value. This deﬁn-
ition can cope with a uniform time constant through health
and disease, the time constant being the result of an equi-
librium between the dynamics the ventricle and the proper-
ties of the pulmonary circulation. When the system is
started, volume accumulates in the pulmonary reservoir
decreasing resistance and compliance until their inverse rela-
tionship is reached, this in turn will determine the pressure.
The other approach is based on a two-element
Windkessel where the time constant is computed as the
product of the resistance and compliance. Based upon the
complex expression of resistance and the complex expres-
sion of compliance, their product can hardly be a uniform
constant. The simplest expression of resistance is the
Poiseuillean expression, with a dependence to the fourth
power of the radius while a simple expression of compliance
is function of the third power of the radius.35 Given the
complexity of the relation (adding the visco-elastic proper-
ties of the arteries and the possibility of recruiting vessels), it
is remarkable that the compliance showed a clear relation-
ship to the resistance when considering the pooled group of
animals (Fig. 6b) with some form of inverse relationship.
The diﬀerences that we observed in the product are
small (RC is in the range of 1.13–2.91 s) but signiﬁcant
and persisted when normalized for weight. Based on our
observations, it would be more accurate to question the
invariability of the resistance/compliance relationship
through health and disease than to question the constancy
of the product, which due to the complexity of the system
could hardly be met.
The constancy of RC is not only relevant from a physio-
logical viewpoint but also has important clinical implica-
tions. If RC is eﬀectively constant and/or the coeﬃcient of
the mPAP/SPAP is constant regardless of the nature or
importance of the pulmonary artery disease, the estimation
of the pulmonary arterial compliance should have no value
in the diagnosis nor the prognosis of an illness because it is
then a surrogate of resistance. This situation has been
described previously.26,36 However, if RC is variable, it
could help to discriminate the nature of PAH according to
studies that have shown discrepancies between the coeﬃ-
cient of the mPAP/SPAP slope or the values of the RC
product.31 Since achieving a continuous ﬂow, which is a
prerequisite for a correct estimation of RC, cannot be
easily obtained in a clinical setting, a reliable independent
estimate of compliance must be identiﬁed to answer the
question of RC constancy.
From a methodological point of view, we wish to add that
there is a concern related to the asymptotic value of the decay
curve included in P¼ (PdiastPasympt)e-t/RCþPasympt.24
Fig. 6. Relationship between resistance and compliance in the pulsatile regime (a) and the continuous flow regime (b) using different methods of
compliance assessment.
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The asymptotic value is the oﬀset pressure that is reached
after an inﬁnite amount of time. Usually, the chosen value
of the asymptotic pressure is the wedge pressure, which is
considered constant. In this experimental setting, the outﬂow
pressure is the left atrial pressure. Filling (and pressure) of the
LA depends on the outﬂow from the right side, which was
discontinued along with the pump interruption, causing the
pressure to decrease; Pasympt is therefore not constant.
Subtracting instantaneous LAP pressure from the PAP
yielded a function that is not an exponential or a reﬂection
of the physiological situation in which the outﬂow is con-
stant. We therefore assumed that Pasympt,¼ 0, thereby sim-
plifying the model while introducing a small error
that aﬀects the pressure decay ﬁtting in such a way that it
underestimates compliance, which only reinforces our
observations.
Pulmonary arterial compliance (and what estimation
method to use in vivo)
Compliance is deﬁned as the volume change due to the pres-
sure change of an enclosed system and is determined by the
volume of the system and its elasticity/distensibility.
Clinically, an impairment of vessel compliance has been
related to a worse outcome.37 Therefore, the correct estima-
tion of compliance is important. However, despite its con-
ceptual simplicity, the practical estimation of compliance is
diﬃcult due to the dynamic nature of the pressure/ﬂow rela-
tionship and the existence of waves. In our novel experimen-
tal model, the pressure curve after the cessation of
ﬂow—and rid of wave interferences—was well ﬁtted by a
mono-exponential decay function during the ﬁrst 500ms.
It was observed that compliance was inversely related to
resistance, which is likely to be explained by the structural
properties of the pulmonary vasculature, including the over-
lap of resistive and compliant vessels. The latter implies that
resistance vessels, upon ‘‘inﬂation’’ with higher imposed
ﬂows, contribute less to resistance, but start to contribute
to the total compliance in the pulmonary arterial system.
One of our main goals was to deﬁne the best in vivo
method for the measurement of compliance, postulating
the measure under continuous ﬂow conditions as gold
standard for the same level of (mean) ﬂow. For every
method used, compliance under pulsatile ﬂow conditions
was substantially lower than that under continuous ﬂow
conditions. Our results also showed large discrepancies
between methods, which has been observed by others.9
Segers et al. found that the SV/PP method overestimates
compliance by 80% compared to the PPM method.11
However, our results showed a more striking observation
in the relationship between the method of compliance
assessment and the vascular resistance. Using our observa-
tion in continuous ﬂow conditions as guidance, one antici-
pates an increase in compliance when the resistance
decreases. A paradoxical decrease in compliance shown in
Table 1 is highlighted in gray. When the method of
compliance computation was based on the systolic part,
such as in the SV/PP method or the PPM method, four of
the ﬁve measures showed a paradoxical decrease in compli-
ance. It occurred in two animals using the area method and
in only one animal using the diastolic decay method.
Overall, quantitative comparison showed a very poor cor-
relation between continuous and pulsatile condition. Since
the inverse relation between resistance and compliance is
unequivocal in respect to the continuous ﬂow regime, we
consider the semi-quantitative observations relating compli-
ance and resistance as valid and the decay time method as
the method showing the closest agreement with the expected
changes, and hence as the method of choice.
The diﬀerent values of compliance according to the
method of measurement question the appropriateness of
each method and the major diﬀerences in compliance
when comparing the pulsatile and continuous ﬂow condi-
tions question the nature itself of a unique value for a global
compliance of the whole lung. A unique value for compli-
ance would imply a linear relation between pressure and
volume which is not true since arteries have visco-elastic
properties showing a curvilinear pressure volume relation
and moreover a three-dimensional elastic container with
increasing volume will have an increasing compliance due
to Laplace’s law.
Just as for resistance, we could argue that a mean value
would be appropriate to draw clinical conclusions. When
computing resistance, the use of mean pressure and mean
ﬂow over the whole cardiac cycle reﬂect mean resistance.
When computing compliance, the diﬀerent methods are
more prone to explore compliance during systole such as
for the PPM method or during diastole such as for the dia-
stolic decay method. Compliance during one phase of the
cardiac cycle can barely be used as a mean value reﬂecting
elastic and geometrical properties of the system. Our experi-
ment pointed out that the distribution of the ﬂow could have
an inﬂuence, uniformly distributed volume induces a high
compliance. In pulsatile ﬂow conditions, due to inertia, the
volume is not instantaneously distributed, and the most
proximal arterial segments are ﬁrst pressurized and
recruited. Measurement of compliance during systole, such
as SV/PP and the pulse pressure method, will yield lower
values, reﬂecting the compliance at higher pressure of a
proximal compartment. The methods that explore a later
phase of the cycle may measure the compliance of a more
uniformly distributed vascular system, thereby indicating
higher values.
Conclusions
In this experiment, we were able to design a model of two-
element Windkessel in the pulmonary circulation using a
continuous pulmonary ﬂow pump. Based on the inverse
relation of resistance and compliance, in pulsatile ﬂow con-
ditions, the decay time method of compliance assessment
yields results in closest agreement with the reference
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method. Absolute value of compliance in pulsatile ﬂow con-
ditions were signiﬁcantly lower than in the continuous ﬂow
conditions whatever the method considered. We speculate
that in vivo, in pulsatile ﬂow conditions, inertial eﬀects lead
to non-uniform distribution of the ﬂow with compartmental
recruitment of compliance. The four diﬀerent methods of
compliance assessment used in our experiment do not
allow to estimate compliance in the entire compartment.
True arterial compliance in the pulmonary circulation
remains diﬃcult to assess. The diﬀerent methods available
are entailed with error and should be used with circumspec-
tion in the clinical setting.
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